CD274 and metastatic neoplasm: No difference in PD-L1 expression was found in patients with high vs. low metastatic disease volume (based on CHAARTED classification: visceral metastases or ≥4 bone lesions with ≥1 beyond the vertebral bodies and pelvis), or among the different metastatic sites.